I now have comprehensive data. Let me compile the full management overview.
Management of Typhoid Fever (Enteric Fever)
1. General Principles
Typhoid fever (caused by Salmonella enterica serotype Typhi) carries an overall case-fatality rate of ~2.5%, rising to 4.5% among hospitalized patients. Prompt antibiotic therapy reduces this dramatically - untreated, mortality is 10-20%. Management is guided by:
- Antibiotic susceptibility pattern of the strain
- Severity of illness
- Presence of complications
- Patient population (adult vs child, pregnancy, immunocompromised)
2. Antibiotic Therapy
A. Uncomplicated Typhoid - By Susceptibility Pattern
Based on Park's Textbook of Preventive and Social Medicine and Harrison's Principles (22nd ed., 2025):
| Susceptibility | Optimal Antibiotic | Dose (mg/kg/day) | Duration | Alternatives |
|---|
| Fully sensitive | Fluoroquinolone (ciprofloxacin or ofloxacin) | 15 | 5-7 days | Chloramphenicol 50-75 mg/kg × 14-21 d; Amoxicillin 75-100 mg/kg × 14 d; TMP-SMX 8-40 mg/kg × 14 d |
| Multidrug resistant (MDR) | Fluoroquinolone OR Cefixime | 15 / 15-20 | 5-7 d / 7-14 d | Azithromycin 8-10 mg/kg × 7 d; Cefixime 15-20 mg/kg × 7-14 d |
| Quinolone-resistant | Azithromycin OR Ceftriaxone | 8-10 / 75 | 7 d / 10-14 d | Cefixime 20 mg/kg × 7-14 d |
Key point on fluoroquinolone resistance: Resistance is rising sharply - especially in travelers from South Asia (India, Pakistan) and Southeast Asia, linked to nalidixic acid-resistant strains. Fluoroquinolones should not be used empirically in these regions. Azithromycin or third-generation cephalosporins are preferred.
A 2024 systematic review (
PMID 39623850) found oral azithromycin to be clinically effective vs other antimicrobials across all age groups, comparable to ceftriaxone in uncomplicated disease.
B. Standard Adult Doses (Oral)
- Ciprofloxacin 500 mg twice daily × 7-10 days (sensitive strains)
- Ofloxacin 400 mg twice daily × 7-10 days
- Azithromycin 1 g daily × 5-7 days (quinolone-resistant areas)
- Cefixime 15-20 mg/kg/day × 7-14 days (MDR strains)
- Ceftriaxone 2 g IV once or twice daily × 10-14 days (severe or parenteral)
Ampicillin, TMP-SMX, and chloramphenicol are now unreliable due to widespread resistance.
- Sleisenger and Fordtran's Gastrointestinal and Liver Disease, p. 2197
- Harrison's Principles of Internal Medicine 22E, p. 1360
3. Severe Typhoid Fever
Severe disease features: high fever with altered sensorium, shock, GI perforation, severe hemorrhage, or typhoid encephalitis/meningitis.
Management:
- Parenteral antibiotics - Ceftriaxone 2 g IV daily × 10-14 days is preferred
- Add dexamethasone in severe cases with delirium, obtundation, stupor, coma, or shock:
- Dose: 8 mg/kg × 1 loading dose, then 1 mg/kg every 6 hours × 48 hours (total 3 days)
- This has been shown to reduce mortality in severe typhoid
- IV fluid resuscitation
- Blood transfusion if hemorrhage causes significant anemia
- Broad-spectrum antibiotic coverage broadened for polymicrobial peritonitis if perforation occurs
- Tintinalli's Emergency Medicine, p. 3387
- Sleisenger and Fordtran's GI Disease, p. 2198
4. Complications and Their Management
| Complication | Timing | Management |
|---|
| Intestinal perforation (1%) | 3rd-4th week | Emergency surgery + broadened antibiotics for peritonitis |
| GI hemorrhage (6%) | 3rd-4th week | Fluid resuscitation, blood transfusion, possibly bowel resection |
| Typhoid encephalitis / meningitis | Any time | Ceftriaxone IV + dexamethasone |
| Relapse | 2-6 weeks post-recovery | Repeat antibiotic course (same agent usually effective) |
| Carrier state | >12 months shedding | See below |
- Harrison's Principles 22E
5. Carrier State Management
Chronic carriers (biliary carriers >1 year) are the ultimate reservoir. Treatment options:
-
Ampicillin or Amoxicillin 4-6 g/day + Probenecid 2 g/day × 6 weeks (bile-concentrated; ~70% eradication)
-
Cholecystectomy + concurrent ampicillin: cure rate up to 80% (best approach for gallbladder carriers)
-
Urinary carriers: antibiotic treatment; refractory cases may need nephrectomy
-
Carriers must be restricted from food handling and kept under surveillance
-
Park's Textbook of Preventive and Social Medicine, p. 279
6. Supportive Care
- Adequate oral or IV hydration
- Antipyretics (paracetamol preferred; avoid NSAIDs if bleeding risk)
- Nutritional support - soft, easily digestible diet
- Monitoring for complications (daily abdominal exam, watch for signs of peritonism)
- Strict enteric precautions and isolation of stool/urine
7. Special Situations
| Situation | Preferred Agent |
|---|
| Pregnancy | Ceftriaxone (fluoroquinolones and chloramphenicol avoided) |
| Children | Cefixime or azithromycin; ceftriaxone for severe disease |
| MDR / XDR typhoid | Azithromycin (oral) or ceftriaxone/meropenem (parenteral) |
| Typhoid with HIV | Standard antibiotics; higher relapse risk - consider longer course |
8. Post-treatment Follow-up
- Relapse occurs in 5-10% of cases, typically 2-3 weeks after apparent recovery - treat with a repeat antibiotic course
- Stool cultures at 1 and 3 months post-treatment to confirm clearance, especially in food handlers
- Vaccination of close contacts and household members
Summary Algorithm
Typhoid suspected (fever >5 days + travel history)
↓
Blood culture + susceptibility testing
↓
Uncomplicated? Severe (altered consciousness/shock/perforation)?
↓ ↓
Check susceptibility Ceftriaxone IV + Dexamethasone
↓
Sensitive strain → Fluoroquinolone (if NOT South/SE Asia)
MDR → Cefixime or Fluoroquinolone
Quinolone-resistant → Azithromycin or Ceftriaxone